Keywords
Physical performance
Walking speed
Adults
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate and diagnose secondary sarcopenia in hospitalized adult patients. Methods: This is a cross-sectional study, conducted with 40 individuals, of both sexes, aged between 18 and 60 years. This study was approved by the Research Ethics Committee and the patients were investigated using sarcopenia diagnostic methods suggested by the European Working Group on Sarcopenia in Older People (EWGSOP-2), through the use of the SARC-F questionnaire, Five-Time Sit-Stand Test, measurement of Calf Circumference and 4-meter Gait Speed Test to classify sarcopenia, in addition to an interview to obtain sociodemographic and clinical data. Results: The average age of the participants was 44.65 years, the majority were female (75%), the highest frequencies in the sample were liver disease, lung disease and kidney disease, where 25% were Probable Sarcopenic (PS), 15 % were identified as sarcopenic and 10% of these had severe sarcopenia. Conclusion: This study identified sarcopenia in hospitalized adults with a history of falls, whose relevance lies in signaling to the team the necessary care to intervene and prevent injuries from prolonged hospitalization.
References
ABREU DCC de, et al. Prediction of Reduced Gait Speed Using 5-Time Sit-to-Stand Test in Healthy Older Adults. Journal of the American Medical Directors Association, 2022; 23(5):889-892.
BOHANNON RW e WANG YC. Four-meter Gait Speed: Normative Values and Reliability Determined for Adults Participating in the NIH Toolbox Study. Archives of Physical Medicine and Rehabilitation, 2019; 100(3):509-513.
BORDA MG, et al. Sarcopenia, lung disease and mortality: a secondary analysis of the CRELES study. Geriatr Gerontol Aging, 2019; 13(1):36-8.
BROUESSARD C, et al. Impact of Severe Sarcopenia on Rehospitalization and Survival One Year After a TAVR Procedure in Patients Aged 75 and Older. Clin Interv Aging, 2021; 16: 1285–1292.
CABANAS-VALDÉS R, et al. Assessment of the 4-meter walk test test-retest reliability and concurrent validity and its correlation with the five sit-to-stand test in chronic ambulatory stroke survivors. Gait & Posture, 2023; 101:8-13.
CESARI M, et al. Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging And Body Composition Study. J Am Geriatr Soc, 2009; 57: 251–9.
CRUZ-JENTOFT AJ, et al. Sarcopenia and severity of non-alcoholic fatty liver disease. Arquivo de Gastroenterologia, 2019; 56(4):357-360.
CRUZ-JENTOFT AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing, 2019; 48: 16–3.
FURLANETTO KC, et al. Reference Values for 7 Different Protocols of Simple Functional Tests: A Multicenter Study. Archives of Physical Medicine and Rehabilitation, 2022; 103(1):20-28.e5.
HE N, et al. Relationship Between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview. Front Cardiovasc Med. 2021; 8:743710.
KARPMAN C, et al. Measuring Gait Speed in the Out-Patient Clinic: Methodology and Feasibility. Respiratory Care, 2014; 59(4):531-7.
KELLER K e ENGELHARDT M. Strength and muscle mass loss with aging process. Age and strength loss. Muscles Ligaments Tendons J, 2014; 3(4): 346–350.
KO JB, et al. Predicting Sarcopenia of Female Elderly from Physical Activity Performance Measurement Using Machine Learning Classifiers. Clin Interv Aging, 2021; 16:1723-1733.
KRISTIANA T, et al. Association between Muscle Mass and Muscle Strength with Physical Performance in Elderly in Surabaya. Surabaya Physical Medicine and Rehabilitation Journal, 2020; 2(1), 24–34.
LANDI F, et al. Calf circumference, frailty and physical performance among older adults living in the community. Clin Nutr, 2014; 33: 539–44.
LEE HX, et al. Combined Impact of Positive Screen for Sarcopenia and Frailty on Physical Function, Cognition and Nutrition in the Community Dwelling Older Adult. Ann Geriatr Med Res, 2021; 25(3):210-216.
MAGGIO M, et al. Instrumental and Non-Instrumental Evaluation of 4-Meter Walking Speed in Older Individuals. PLoS ONE, 2016; 11(4):e0153583.
MALMSTROM T, et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. Journal of Cachexia, Sarcopenia and Muscle, 2016; 7(1):28-36.
MARTINEZ BP, et al. Massa e força muscular em idosos. Revista Brasileira de Geriatria e Gerontologia, 2016; 19(2):257-264.
MCLEAN RR e KIEL DP. Developing Consensus Criteria for Sarcopenia: An Update. Journal of Bone and Mineral Research, 2015; 30(4):588-92.
MELO TA de, et al. Teste de Sentar-Levantar Cinco Vezes: segurança e confiabilidade em pacientes idosos na alta da unidade de terapia intensiva. Rev Bras Ter Intensiva, 2019; 31(1):27-33.
NOLAN CM, et al. Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study. European Respiratory Journal, 2019; 53: 1801186.
PARRA BFCS, et al. SARC-PRO Proposta de protocolo de sarcopenia em pacientes internados. BRASPEN J, 2019; 34 (1): 58-63
PETERS DM, et al. Assessing the reliability and validity of a shorter walk test compared with the 10-Meter Walk Test for measurements of gait speed in healthy, older adults. J Geriatr Phys Ther., 2013; 36(1):24-30.
PPINIJMUNG P, et al. Prevalence and Impact of Sarcopenia in Heart Failure: A Cross-Sectional Study. The Open Cardiovascular Medicine Journal, 2022; 16 (2202240) 1874-1924.
RIBEIRO HS, et al. Association between sarcopenia and clinical outcomes in chronic kidney disease patients: A systematic review and meta-analysis. Clinical Nutrition, 2022; 41 (5) 1131-1140.
RODRIGUES F, et al. A review on aging, sarcopenia, falls and resistance training in community-dwelling elderly. Int. J. Environ. Res. Public Health, 2022; 19(2): 874.
SANTOS KPC, et al. Avaliação nutricional de pacientes com doença hepática crônica: comparação entre diferentes métodos. BRASPEN J, 2018; 33 (2): 170-5.
SOUZA IP, et al. Utilização do SARC-F para triagem de sarcopenia em pacientes adultos hospitalizados, Ntr Clín Diet Hosp., 2020; 40(3): 99-105.
SPATZ ES, et al. Community factors and hospital wide readmission rates: Does context matter? PLoS ONE 1. 2020; 10(0240222).
VAN PUYENBROECK K, et al. The Additional Value of Bioelectrical Impedance Analysis-Derived Muscle Mass as a Screening Tool in Geriatric Assessment for Fall Prevention. Gerontology, 2012; 58(5):407-12.
WALLMANN HW, et al. Interrater reliability of the fivetimes-sit-to-stand test. Home Health Care Manag Pract. 2012; 25(1):13-17.
WAN M, et al. Cellular senescence in musculoskeletal homeostasis, diseases, and regeneration. Bone Res., 2021;9(1):41.
WELCH C, et al. Acute Sarcopenia Secondary to Hospitalisation - An Emerging Condition Affecting Older Adults. Aging Dis., 2018; 9(1):151-164.
ZHANG X, et al. Falls among older adults with sarcopenia dwelling in nursing home or communCOBOity: A meta-analysis. Clin Nutr., 2020; 39(1):33-39.